Tanner Pharma and Biodexa Pharmaceuticals partner to provide global access to eRapa through an Early Access / Named Patient Program, supporting patients with Familial Adenomatous Polyposis (FAP) where no approved treatments exist.

TannerCares supported an employee-led hurricane relief effort in Jamaica, bringing together teams across Tanner to deliver essential supplies, coordinate logistics, and provide direct support to communities impacted by the storm.

Tanner Pharma Group has been recognised as one of the Charlotte Business Journal’s Best Places to Work, reflecting a culture shaped by collaboration, shared purpose, and a commitment to improving access to medicines worldwide.

Jonathan Bracey shared his son George’s experience with an ultra-rare disease, highlighting the challenges families face and the importance of collaboration, research, and access in advancing care.

Tanner Pharma Group and UCB Pharma have initiated a partnership in Southeast Asia to support access to innovative epilepsy treatments for patients across the region.

Tanner Pharma Group has expanded its US operations with a new facility in Charlotte, enhancing its capabilities in clinical trial support, secondary packaging, and global distribution.

Tanner Pharma has partnered with Agenus to expand global access to investigational immunotherapies through a Named Patient Program for patients with advanced cancers.

Azienda Farmaceutica Italiana (“AFI”), an Italian pharmaceutical company and innovator in therapeutic solutions and new treatment possibilities, and TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, have entered into a license agreement for the distribution of Hepilor® in Latin America.

Tanner Pharmaceuticals, Inc., a global pharma services company that provides access to pharmaceuticals through Global Access Programmes and Clinical Trials Sourcing, and BurnsAdler Pharmaceuticals, a specialty pharmaceutical company that licenses and acquires pharmaceuticals, medical devices and over-the-counter (OTC) products for commercialization in Latin America and other international markets, have merged to form Tanner Pharma Group, company officials announced today.